From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
AZBio Members have access to substantial VWR discounts via the BIO Business Solutions®
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
Alex Gorsky, chairman and CEO of Johnson & Johnson, one of several companies that’s developed a potential coronavirus vaccine, tells TODAY that his company has a candidate “that has a high degree of probability of being successful.” He anticipates starting tests in humans in September and says “We could have vaccines ready in Q1 and […]
ABBOTT LAUNCHES MOLECULAR POINT-OF-CARE TEST TO DETECT NOVEL CORONAVIRUS IN AS LITTLE AS FIVE MINUTES – The Abbott ID NOW™ COVID-19 test brings rapid testing to the front lines – Test to run on Abbott’s point-of-care ID NOW platform – a portable instrument that can be deployed where testing is needed most – ID NOW […]
The University of Arizona Cancer Center will receive $1.4 million as a collaborating center with the national network of academic, public health and community partners, working together to reduce the burden of cancer, especially among Hispanic cancer survivors.
- Biopreneur Business Brief
- FDA Webinar - Clinical Laboratory Improvement Amendments (CLIA) Waiver Applications Final Guidances
- AZBioPEERS: Fundraising Tales From The Road - Webcast
- The Digital MedTech Conference
- 05/19/2020 - 05/20/2020
- Los Angeles
- Arizona Bioscience Week - AZBW 2020
- 09/13/2020 - 09/19/2020